WebA Safety and Performance Assessment of the Affera SpherePVI™ Multi-Ablation System to Treat Paroxysmal Atrial Fibrillation: NCT05115214: Interventional: No Results: Posted: 2024-11-10: Start: 2024-10-19: Results: None: Primary: 2024-10-19: Complete: 2024-10-19 WebAffera, Inc. Announces Successful First-In-Human Use Of SpherePVI Circumferential Pulmonary Vein Isolation Device Using Pulsed Field Energy
History of Changes for Study: NCT05144503 - clinicaltrials.gov
WebCTO 2024. Stay up-to-date with breaking news, conference slides, and topical videos covering the spectrum of CVD. WebOct 20, 2024 · SpherePVI™ Catheter handling sufficient to reach reasonable intended targets, as determined by the physician: catheter delivery to the desired ablation sites completion of ablation procedure safe removal of catheter from the subject Electroanatomical navigation and/or mapping sufficient to aid the procedure (if used) is all laundry detergent toxic
Safety and Performance of the Affera SpherePVI™ Multi-Ablation …
WebOfficial Title: A Safety and Performance Assessment of the SpherePVI™ Catheter and the Affera Mapping and Ablation System to Treat Paroxysmal Atrial Fibrillation. Actual Study … WebNov 16, 2024 · The safety profile of cryoballoon ablation has been established in patients whose condition does not respond to drug therapy, with complications occurring in approximately 6% of patients during... WebSpherePVI is a novel 8F over-the-wire multi-segment lattice tip catheter designed to efficiently deliver circumferential pulmonary vein isolation. The catheter is integrated with … is all lumber treated with chemicals